Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Development of a very rapid diagnostic test for malaria, based on break-through detection technology and new biomarkers of infection.

Ziel

The overall project objective is to develop and bring to market a very rapid diagnostic test (V-RDT) for malaria, based on break-through detection technology and particularly relevant biomarkers of infection.

Our ambition is for our diagnostic device to become the reference technology in all malaria endemic areas.

A key advantage of our approach lies in the combination of an innovative detection device with novel biomarkers that should significantly improve the quality of testing and the ability to implement mass testing campaigns.

Our device is expected to overcome most shortcomings identified in devices currently on the market. The expected added value of our proposed diagnostic device to users is multiple including:
• Rapidity: 1 minute vs. 15-20 minutes required for most current tests. This is a major competitive advantage for cross-sectional testing necessary for eradication efforts;
• High sensitivity including quantitative evaluations (picomolar detection);
• Several simultaneous measures to distinguish parasite species (P. falciparum / P. vivax);
• Infection parameters (parasite density and antibody response): the comprehensive nature of our diagnostic read-outs provide information on prognosis and/or therapeutic response in addition to simple yes/no diagnoses; and
• Functional and reliable in expected field conditions (tropical environments). .

Wissenschaftliches Gebiet (EuroSciVoc)

Dieses Projekt wurde noch nicht bei EuroSciVoc klassifiziert.
Schlagen Sie die Wissenschaftsbereiche vor, die Ihrer Einschätzung nach besonders relevant sind, und helfen Sie uns, unseren Klassifizierungsdienst zu verbessern.

Programm/Programme

Thema/Themen

Finanzierungsplan

SME-1 - SME instrument phase 1

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) H2020-SMEInst-2014-2015

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

VAXIMAX
Netto-EU-Beitrag
€ 50 000,00
Adresse
4 RUE PIERRE FONTAINE CAMPUS 3
91058 Evry
Frankreich
KMU
Ja
Region
Ile-de-France Ile-de-France Essonne
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Gesamtkosten
€ 71 429,00

Beteiligte (1)